Is there benefit in implanting defibrillators in patients with severe heart failure?

Heart

Volumn 96, Issue 8, 2010, Pages 599-603

  Salukhe, Tushar V ^a   Briceno, Natalia I ^a   Ferenczi, Emily A ^a   Sutton, Richard ^a   Francis, Darrel P ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DEFIBRILLATOR; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; IMPLANTATION; MORTALITY; PRIORITY JOURNAL; RISK FACTOR;

DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77950553290     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2009.179515     Document Type: Article

References (19)

1. National Institute for Health and Clinical Excellence [Homepage on the Internet]. NICE guidelines on cardiac resynchronisation therapy (CRT) and implantable cardiac defibrillators (ICDs). http://www.nice.org.uk/nicemedia/pdf/ TA95ImplementationAdvice.pdf (accessed Jan 2006).
2. Wever EFD, Hauer RNW, van Capelle FJL, et al. Randomised study of implantable defibrillator as first-choice therapy versus conventional strategy in post-infarct sudden death survivors. Circulation 1995;91:2195-2203
3. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implantable defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. The Multi-centre Automated Defibrillator Implantation Trial (MADIT) investigators. N Engl J Med 1996;335:1933-1940.
4. Schläpfer J, Rapp F, Kappenberger L, et al. Electrophysiological guided amiodarone therapy versus the implantable cardioverter-defibrillator for sustained ventricular tachyarrhymias after myocardial infarction. J Am Coll Cardiol 2002;39:1813-1819
5. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150
6. Altman D, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003;326:219.
7. Bardy GH, Lee KL, Mark DB, et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237
8. Moss AJ, Zareba W, Hall WJ, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883
9. Zareba W, Piotrowicz K, McNitt S, et al. MADIT II Investigators. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population). Am J Cardiol 2005;95:1487-1491
10. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583
11. Kuck KH, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-754
12. Connolly SJ, Gent M, Roberts RS, et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-1302
13. Kadish A, Dyer A, Daubert JP, et al. Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151-2158
14. Narang R, Cleland JG, Erhardt L, et al. Mode of death in chronic heart failure. A request and proposition for more accurate classification. Eur Heart J 1996;17:1390-1403
15. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006;113:1424-1433
16. Mozaffarian D, Anker SD, Anand I, et al. Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Circulation 2007;116:392-398
17. Böcker D, Bänsch D, Heinecke A, et al. Potential benefit from implantable cardioverter-defibrillator therapy in patients with and without heart failure. Circulation 1998;98:1636-1643
18. Tandri H, Griffith LS, Tang T, et al. Clinical course and long-term follow-up of patients receiving implantable cardioverter-defibrillators. Heart Rhythm 2006;3:762-768
19. Trappe HJ, Wenzlaff P, Pfitzner P, et al. Long-term follow up of patients with implantable cardioverter-defibrillators and mild, moderate, or severe impairment of left ventricular function. Heart 1997;78:243-249